CD161,Th1

Briana Amicarella Burns1, Manasvi Chandra1, Vanaja Konduri1,2

  • 1Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States.

PubMed
概括

CD8+CD161+T细胞与更好的癌症存活率和免疫力有关. 它们的表达,特别是与树突细胞的表达,表明作为治疗生物标志物和点的潜力.